SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-04-008696
Filing Date
2004-03-29
Accepted
2004-03-29 15:51:42
Documents
12
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a04-3806_110k.htm 10-K 1325985
3 EX-10.43 a04-3806_1ex10d43.htm EX-10.43 8319
4 EX-10.44 a04-3806_1ex10d44.htm EX-10.44 148592
5 EX-10.45 a04-3806_1ex10d45.htm EX-10.45 109889
6 EX-21.1 a04-3806_1ex21d1.htm EX-21.1 6104
7 EX-23.1 a04-3806_1ex23d1.htm EX-23.1 4425
8 EX-31.1 a04-3806_1ex31d1.htm EX-31.1 13452
9 EX-31.2 a04-3806_1ex31d2.htm EX-31.2 12717
10 EX-32 a04-3806_1ex32.htm EX-32 6763
11 GRAPHIC g38061keimage002.jpg GRAPHIC 3916
12 GRAPHIC g38061baimage002.gif GRAPHIC 17510
13 GRAPHIC g38061baimage004.gif GRAPHIC 11966
  Complete submission text file 0001104659-04-008696.txt   1672488
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23413 | Film No.: 04695999
SIC: 2835 In Vitro & In Vivo Diagnostic Substances